- Home
- TRIB vs IMNN Comparison
TRIB vs IMNN Comparison
Compare TRIB & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- IMNN
- Stock Information
- Founded
- TRIB 1992
- IMNN 1982
- Country
- TRIB Ireland
- IMNN United States
- Employees
- TRIB N/A
- IMNN N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- IMNN Health Care
- Exchange
- TRIB Nasdaq
- IMNN Nasdaq
- Market Cap
- TRIB 12.3M
- IMNN 14.3M
- IPO Year
- TRIB N/A
- IMNN 1985
- Fundamental
- Price
- TRIB $1.28
- IMNN $0.66
- Analyst Decision
- TRIB
- IMNN Strong Buy
- Analyst Count
- TRIB 0
- IMNN 2
- Target Price
- TRIB N/A
- IMNN $20.50
- AVG Volume (30 Days)
- TRIB 162.5K
- IMNN 206.2K
- Earning Date
- TRIB 11-15-2024
- IMNN 11-07-2024
- Dividend Yield
- TRIB N/A
- IMNN N/A
- EPS Growth
- TRIB N/A
- IMNN N/A
- EPS
- TRIB N/A
- IMNN N/A
- Revenue
- TRIB $59,126,000.00
- IMNN N/A
- Revenue This Year
- TRIB $17.64
- IMNN N/A
- Revenue Next Year
- TRIB $9.84
- IMNN N/A
- P/E Ratio
- TRIB N/A
- IMNN N/A
- Revenue Growth
- TRIB N/A
- IMNN N/A
- 52 Week Low
- TRIB $1.05
- IMNN $0.48
- 52 Week High
- TRIB $3.55
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- TRIB 34.96
- IMNN 22.88
- Support Level
- TRIB $1.24
- IMNN $0.65
- Resistance Level
- TRIB $1.40
- IMNN $0.84
- Average True Range (ATR)
- TRIB 0.16
- IMNN 0.08
- MACD
- TRIB -0.05
- IMNN -0.01
- Stochastic Oscillator
- TRIB 8.82
- IMNN 6.12
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.